 |
PDBsum entry 2trh
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Amyloid
5:175-187
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation.
|
|
N.Schormann,
J.R.Murrell,
M.D.Benson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The most common form of hereditary systemic amyloidosis is familial amyloidotic
polyneuropathy associated with single amino acid changes in the plasma protein
transthyretin. So far, high resolution structures of only three amyloidogenic
variants (Met30, Ser84, Ile122) and one non-amyloidogenic variant (Thr109) have
been reported complemented by X-ray fiber diffraction studies and image
reconstruction from electron micrographs of amyloid fibrils. To investigate the
role of structural factors in this disease, we extended our studies to other
transthyretin variants. We report crystallization and structural investigations
of three amyloidogenic (Arg10, Ala60, Tyr77) and two non-amyloidogenic variants
(Ser6, Met119). The similarity of these structures to normal transthyretin does
not give direct clues to the fibril forming process. Since transthyretin amyloid
fibrils contain a major fragment starting at position 49, besides the intact
molecule, we calculated the solvent accessibility of residue 48. Indeed, all
amyloidogenic variants show an increased main chain solvent exposure when
compared to normal transthyretin and non-amyloidogenic variants, which can be
postulated to result in increased susceptibility to proteolysis. After limited
proteolysis, dimers are incapable of reassociation to native tetramers. We
present a model for amyloid fibril formation based on formation of fibrils from
N-terminal truncated dimers as building blocks.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Cendron,
A.Trovato,
F.Seno,
C.Folli,
B.Alfieri,
G.Zanotti,
and
R.Berni
(2009).
Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses.
|
| |
J Biol Chem,
284,
25832-25841.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Lavatelli,
D.H.Perlman,
B.Spencer,
T.Prokaeva,
M.E.McComb,
R.Théberge,
L.H.Connors,
V.Bellotti,
D.C.Seldin,
G.Merlini,
M.Skinner,
and
C.E.Costello
(2008).
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
|
| |
Mol Cell Proteomics,
7,
1570-1583.
|
 |
|
|
|
|
 |
G.Zanotti,
C.Folli,
L.Cendron,
B.Alfieri,
S.K.Nishida,
F.Gliubich,
N.Pasquato,
A.Negro,
and
R.Berni
(2008).
Structural and mutational analyses of protein-protein interactions between transthyretin and retinol-binding protein.
|
| |
FEBS J,
275,
5841-5854.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.G.Ghosh,
S.A.Houck,
and
J.I.Clark
(2008).
Interactive sequences in the molecular chaperone, human alphaB crystallin modulate the fibrillation of amyloidogenic proteins.
|
| |
Int J Biochem Cell Biol,
40,
954-967.
|
 |
|
|
|
|
 |
M.Mizuguchi,
A.Hayashi,
M.Takeuchi,
M.Dobashi,
Y.Mori,
H.Shinoda,
T.Aizawa,
M.Demura,
and
K.Kawano
(2008).
Unfolding and aggregation of transthyretin by the truncation of 50 N-terminal amino acids.
|
| |
Proteins,
72,
261-269.
|
 |
|
|
|
|
 |
X.Hou,
M.I.Aguilar,
and
D.H.Small
(2007).
Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
|
| |
FEBS J,
274,
1637-1650.
|
 |
|
|
|
|
 |
M.Calamai,
F.Chiti,
and
C.M.Dobson
(2005).
Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.
|
| |
Biophys J,
89,
4201-4210.
|
 |
|
|
|
|
 |
M.A.Liz,
C.J.Faro,
M.J.Saraiva,
and
M.M.Sousa
(2004).
Transthyretin, a new cryptic protease.
|
| |
J Biol Chem,
279,
21431-21438.
|
 |
|
|
|
|
 |
G.Moraitakis,
and
J.M.Goodfellow
(2003).
Simulations of human lysozyme: probing the conformations triggering amyloidosis.
|
| |
Biophys J,
84,
2149-2158.
|
 |
|
|
|
|
 |
Y.Shinohara,
M.Mizuguchi,
K.Matsubara,
M.Takeuchi,
A.Matsuura,
T.Aoki,
K.Igarashi,
H.Nagadome,
Y.Terada,
and
K.Kawano
(2003).
Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy.
|
| |
Biochemistry,
42,
15053-15060.
|
 |
|
|
|
|
 |
G.Goldsteins,
H.Persson,
K.Andersson,
A.Olofsson,
I.Dacklin,
A.Edvinsson,
M.J.Saraiva,
and
E.Lundgren
(1999).
Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants.
|
| |
Proc Natl Acad Sci U S A,
96,
3108-3113.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |